Based on preliminary unaudited financial information, the company expects total revenue, which includes license and royalty revenue from partners, to be approximately $30M for the fourth quarter 2024 and approximately $145M for the full year 2024, and U.S. XPOVIO net product revenue to be approximately $29M for the fourth quarter 2024 and approximately $113M for the full year 2024. FY24 revenue consensus $152.89M.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener